Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ELDN holding history

Eledon Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELDN overviewAll 13F holders of ELDNFull Q2 2026 holdings

Shares (Q2 2026)
485,092
Value
$1.91M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ELDN by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026485,092$1.91M<0.1%+339,934+234.2%AddedHolders
Q1 2026145,158$447.1K<0.1%−95,387−39.7%ReducedHolders
Q4 2025240,545$363.2K<0.1%+1,386+0.6%AddedHolders
Q3 2025239,159$619.4K<0.1%−106,470−30.8%ReducedHolders
Q2 2025345,629$936.7K<0.1%+123,672+55.7%AddedHolders
Q1 2025221,957$752.4K<0.1%+47,451+27.2%AddedHolders
Q4 2024174,506$719.0K<0.1%+91,035+109.1%AddedHolders
Q3 202483,471$207.8K<0.1%+81,316+3,773.4%AddedHolders
Q2 20242,155$5.69K<0.1%00.0%UnchangedHolders
Q1 20242,155$4.44K<0.1%00.0%UnchangedHolders
Q4 20232,155$3.88K<0.1%00.0%UnchangedHolders
Q3 20232,155$2.95K<0.1%00.0%UnchangedHolders
Q2 20232,155$2.95K<0.1%+2,155NewHolders
Q1 20230$00.0%−1−100.0%Sold outHolders
Q4 20221$2<0.1%−1,132−99.9%ReducedHolders
Q3 20221,133$3.00K<0.1%−899−44.2%ReducedHolders
Q2 20222,032$5.00K<0.1%+278+15.8%AddedHolders
Q1 20221,754$7.00K<0.1%−7,017−80.0%ReducedHolders
Q4 20218,771$39.0K<0.1%−100,685−92.0%ReducedHolders
Q3 2021109,456$677.0K<0.1%−741,548−87.1%ReducedHolders
Q2 2021851,004$6.73M<0.1%+839,403+7,235.6%AddedHolders
Q1 202111,601$124.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.